Johnson Pharmacare
Johnson Pharmacare Share Price Chart
Johnson Pharmacare last traded at ₹0.44 (2026-10-13). Over the past month the stock moved -6.4%, three months the stock moved -20.0%, year the stock moved -43.6%. Its closing range over 52 weeks is ₹0.42 – ₹0.64, with the latest close 31.3% below the high.
Closing prices up to 2026-10-13.
About Johnson Pharmacare
Incorporated in 1994, Johnson Pharmacare Ltd. (formerly Robinson Worldwide Trade Ltd) is involved in trading business and provides business services.
Services Offered:[1] Company used to provide commercial services like purchase and sales of various good and services. Company also buys, trades, and sells shares and investments.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Johnson Pharmacare reported sales of ₹0.00 crore and net profit of ₹-1.10 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.04 | – | -1.10 | -0.02 |
| Mar 2026 | 0.00 | -42.70 | – | -55.61 | -1.01 |
| Dec 2025 | 0.00 | -0.02 | – | -0.06 | 0.00 |
| Sep 2025 | 0.00 | 0.00 | – | 0.00 | 0.00 |
| Jun 2025 | 0.00 | -0.05 | – | -0.05 | 0.00 |
| Mar 2025 | 0.00 | -0.01 | – | -0.51 | -0.01 |
| Dec 2024 | 0.00 | -0.03 | – | -0.03 | 0.00 |
| Sep 2024 | 0.00 | 0.00 | – | 0.00 | 0.00 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | – | – | – | – | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Johnson Pharmacare reported sales of ₹0.00 crore and net profit of ₹-56.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.00 | -43.00 | – | -56.00 | -1.01 |
| Mar 2025 | 0.00 | -0.08 | – | -0.58 | -0.01 |
| Mar 2024 | 0.00 | -0.20 | – | -0.20 | 0.00 |
| Mar 2023 | 2.53 | 0.22 | 8.70 | -1.29 | -0.02 |
| Mar 2022 | 3.26 | 0.13 | 3.99 | 0.10 | 0.00 |
| Mar 2021 | 0.76 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mar 2020 | 0.00 | -0.09 | – | -0.09 | 0.00 |
| Mar 2019 | 0.92 | -0.01 | -1.09 | -0.01 | 0.00 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | -100.0% | – | +328.9% | -22.4% | -100.0% | – | – |
| Operating profit growth | – | – | – | – | +69.2% | -190.9% | – | – |
| Net profit growth | – | – | – | – | -1390.0% | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | -1.1% | – | 0.0% | 4.0% | 8.7% | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
AI Analysis
No AI analysis generated yet for Johnson Pharmacare.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Johnson Pharmacare.
Frequently Asked Questions
What is the share price of Johnson Pharmacare today?
Johnson Pharmacare shares were last quoted at ₹0.44 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Johnson Pharmacare?
Johnson Pharmacare has a price-to-earnings (P/E) ratio of -0.44 and a price-to-book (P/B) ratio of 0.00. The industry P/E is 29.85.
What is the 52-week high and low of Johnson Pharmacare?
The 52-week high of Johnson Pharmacare is ₹0.78 and the 52-week low is ₹0.43.
What is the market cap of Johnson Pharmacare?
The market capitalisation of Johnson Pharmacare is about ₹24.75 crore.
How did Johnson Pharmacare perform in its latest quarterly results?
In the latest quarter (Jun 2026), Johnson Pharmacare reported sales of ₹0.00 crore and net profit of ₹-1.10 crore, compared with the same quarter last year.
Is Johnson Pharmacare a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Johnson Pharmacare has a 3-year ROE of -30.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Which sector does Johnson Pharmacare belong to?
Johnson Pharmacare belongs to the Trading sector.